Skip to main content


Hepatology International

Hepatology International OnlineFirst articles

25.02.2020 | Original Article Open Access

Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study

To offer effective treatment responses towards hepatitis B virus (HBV) infections, eight FDA-approved drugs belonging to two classes are currently available, including two interferon alfa drugs and six nucleos(t)ide analogs [ 1 ]. HBeAg …

25.02.2020 | Original Article

Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer

Hepatitis B virus (HBV) integration has been known to occur in hepatocellular carcinoma (HCC) as well as chronic liver infection [ 1 , 2 ]. Double-stranded linear DNA (dslDNA) seems to be preferred DNA substrate for integration [ 2 ]. Recently, the …

25.02.2020 | Original Article Open Access

Applied precision cancer medicine in metastatic biliary tract cancer

Biliary tract cancer (BTC) is a highly malignant and fatal cancer that arises from the biliary epithelium in the bile duct, gall bladder, or ampulla of Vater. The term BTC encompasses several entities: gallbladder carcinoma, distal …

25.02.2020 | Original Article

Effect of hepatitis B surface antibody in patients with core antibody-positive liver transplantation: a systematic review and meta-analysis

Liver transplantation (LT) is the standard of care for patients with end-staged liver disease and early non-resectable hepatocellular carcinoma (HCC). Despite the recent advances in LT, there is a widening gap between the availability of liver …

20.02.2020 | Original Article

Precise fibrosis staging with shear wave elastography in chronic hepatitis B depends on liver inflammation and steatosis

Chronic hepatitis B (CHB) infection remains the predominant causes of liver-related mortality, with approximately 248 million carriers globally [ 1 ]. CHB-related fibrosis has been recognized as the hallmark of progression from mild hepatitis to …

Aktuelle Ausgaben

Über diese Zeitschrift

Hepatology International is a peer-reviewed journal featuring articles written by clinicians, clinical researchers and basic scientists is dedicated to research and patient care issues in hepatology. This journal focuses mainly on new and emerging diagnostic and treatment options, protocols and molecular and cellular basis of disease pathogenesis, new technologies, in liver and biliary sciences.

Hepatology International publishes original research articles related to clinical care and basic research; review articles; consensus guidelines for diagnosis and treatment; invited editorials, and controversies in contemporary issues. The journal does not publish case reports..

Hepatology International requests that all authors comply to Springer’s ethical policies. These ethical statements should be clearly indicated on all articles for all 3 ethics statements and for all authors mentioned by name. These statements should be placed at the end of each article just before the Reference section.

To visit our ethics statements please visit the following links:

Conflict of Interest and Ethical Standards:

Informed Consent:

Statement of Human and Animal Rights:

Hepatology International is the official journal of the Asian Pacific Association for the Study of the Liver (APASL).

Now indexed by ISI

Weitere Informationen

Neu im Fachgebiet Innere Medizin

Meistgelesene Bücher aus der Inneren Medizin

2017 | Buch

Rheumatologie aus der Praxis

Entzündliche Gelenkerkrankungen – mit Fallbeispielen

Dieses Fachbuch macht mit den wichtigsten chronisch entzündlichen Gelenk- und Wirbelsäulenerkrankungen vertraut. Anhand von über 40 instruktiven Fallbeispielen werden anschaulich diagnostisches Vorgehen, therapeutisches Ansprechen und der Verlauf …

Rudolf Puchner

2016 | Buch

Ambulant erworbene Pneumonie

Was, wann, warum – Dieses Buch bietet differenzierte Diagnostik und Therapie der ambulant erworbenen Pneumonie zur sofortigen sicheren Anwendung. Entsprechend der neuesten Studien und Leitlinien aller wichtigen Fachgesellschaften.

Santiago Ewig

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin